Close
Adolfo "Enrique" Diaz Duque, MD, MS
NOTE : If you're an existing patient, please connect via MyChart
-
About Me
About Adolfo "Enrique" Diaz Duque, MD, MS
Enrique Diaz, MD, is an associate professor in the Division of Hematology and Oncology at The University of Texas Health Science Center at San Antonio and leader of the adult lymphoma program at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center.
His research and clinical interests focus on improving outcomes in lymphoma patients. He currently serves as an Ambassador for the American Society of Hematology.
Now enrolling patients in the following studies:
Gender
- Male
Languages Spoken
- English
- Spanish
-
Credentials
Credentials
Positions
- Associate Professor, Division on Hematology and Oncology, University of Texas Health Science Center San Antonio
Certifications
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Medical Oncology
Education
- Medical School: Pontificia Universidad Javeriana, Bogota, Colombia
- Fellowship: Hematology-Oncology, University of Texas Health Science Center San Antonio, San Antonio, TX
- Residency: New York University, New York, NY
- Internship: New York University, New York, NY
- Graduate: MS, Clinical Investigation and Translational Science, University of Texas Health Science Center San Antonio, San Antonio, TX
-
Locations & Contact
Locations & Contact
I really appreciate that every time I visit Dr. Diaz he knows my circumstances and has a plan for me.
Patient
-
Research & Publications
Research & Publications
Impact of Co-Morbidities on Outcome in a Predominantly Hispanic Population of Hodgkin and Non-Hodgkin Lymphoma Patients
Michelle Janania Martinez, MD, Juan F Garza, MD, Tyler W Snedden, MD, Prathibha Surapaneni, MD, Snegha Ananth, MBBS, Jeremy Rawlings, MD, David J Gregorio, DO, Sushanth Kakarla, MD, Qianqian Liu, PhD, Joel E Michalek, PhD, Adolfo Enrique Diaz, MD
Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
William Kelly, Adolfo Enrique Diaz Duque, Joel Michalek, Brandon Konkel, Laura Caflisch, Yidong Chen, Sarath Chand Pathuri, Vinu Madhusudanannair-Kunnuparampil, John Floyd, Andrew Brenner
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
Iman Abou Dalle, Jorge E. Cortes, Pramod Pinnamaneni, Betty Lamothe, Adolfo Diaz Duque, Jasleen Randhawa, Naveen Pemmaraju, Elias Jabbour, Alessandra Ferrajoli, William G. Wierda, Zeev Estrov, Marina Konopleva, Farhad Ravandi, Yesid Alvarado, Gautam Borth
-
Clinical Trials
Clinical Trials
Type of Cancer
Other Hematopoietic
ClinicalTrials.gov Identifier
NCT02736357
Principal Investigator
Adolfo "Enrique" Diaz Duque, MD, MS
LS0386, Clinical and Epidemiological Studies in Lymphoma (CTMS#18-0162)
The goal of this infrastructure grant is to establish and maintain a cohort of over 12,000 non-Hodgkin lymphoma (NHL) patients to support broad and cutting-edge research that identifies clinical (including co-morbid diseases), epidemiologic (including lifestyle and other exposures), host genetic, tumor, and treatment factors, as well as the interaction among these factors, on short and long-term…
Type of Cancer
Hematological Malignancy
ClinicalTrials.gov Identifier
NCT06977711
Principal Investigator
Adolfo "Enrique" Diaz Duque, MD, MS
Phase Ib Clinical Trial of Loncastuximab and Roflumilast Added to R-CHOP (Lo-RR-CHOP) for Treatment Naïve High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
This study is an investigator-initiated, phase I, single arm, open label clinical trial that will enroll subjects with untreated diffuse large B-cell lymphoma (DLCBL) at high risk for poor outcome, defined as an NCCN-IPI score of 2 or higher.